Hyperion Acquires Buphenyl Rights Hyperion Therapeutics, Inc. acquired global rights to Buphenyl tablets and powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharma
June 10, 2013 - Zacks via Yahoo! Finance
Hyperion Acquires Buphenyl Rights - Analyst Blog Hyperion Therapeutics, Inc. ( HPTX ) recently acquired global rights to Buphenyl tablets and powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals ( VRX )
June 10, 2013 - Nasdaq
Larry Ellison in CNET News.com The acquisition of Hyperion makes Oracle the category leader in the high-growth enterprise performance management market,Larry Ellison, Oracle's chief executive, said in a statement.
Cal Ripken Jr in NewsBlaze The first book in the series-Hotheadâ€"will be published in Winter 2011 under the Disney-Hyperion imprint. It centers on all-star third baseman Connor Sullivan, who has a big problem: his temper. The story was inspired by Cal's own struggle with...
Dean Koontz in MarketWatch Of the deal Koontz says: "Writing about our marvelous and funny Trixie, about how she changed our lives, about love and loss, and about the mystery and wonder of the human-dog bond will give me enormous pleasure, as will working with the Hyperion...